CSIMarket Company Name, Ticker, Suppliers, else..
 
Biodexa Pharmaceuticals Plc  (NASDAQ: BDRX)
 

BDRX's Market share relative to its competitors, as of Q4 2025

As of Q4 2025 (Revenue in Millions of $)

Date modified: 2026-05-28T05:59:09+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q4 2025		 MARKET SHARE
12 Months
Q4 2025		 MARKET SHARE
MRQ
Q4 2025		 MARKET SHARE
A Quarter Before
Q3 2025
Biodexa Pharmaceuticals Plc 0.38 0.00% 0.00 % 0.00 %
Amgen Inc 45,369.00 56.44% 53.40% 51.09%
Teva Pharmaceutical Industries Limited 17,350.00 21.58% 22.00% 23.61%
Viatris Inc 14,562.60 18.11% 19.95% 20.85%
Acadia Pharmaceuticals Inc 1,095.25 1.36% 1.64% 1.59%
Intra cellular Therapies Inc 680.85 0.85% 1.06% 1.04%
14 more competitors available

Sign in to see all competitors for Biodexa Pharmaceuticals Plc.

Sign In Create Free Account



BDRX's Market share relative to its competitors, as of Q4 2025 within the Major Pharmaceutical Preparations Industry
As of Q4 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2025		 MARKET SHARE
12 Months Ending
Q3 2025		 MARKET SHARE
MRQ
Q4 2025		 MARKET SHARE

Q3 2025
Biodexa Pharmaceuticals Plc 0.00% 0.00% 0.00 % 0.00 %
Teva Pharmaceutical Industries Limited 49.54% 49.94% 47.21% 48.28%
Viatris Inc 41.58% 41.38% 42.82% 42.63%
Acadia Pharmaceuticals Inc 3.13% 3.10% 3.51% 3.25%
Intra cellular Therapies Inc 1.94% 1.78% 2.27% 2.13%
Ardelyx inc 1.22% 1.18% 1.38% 1.15%
13 more companies available

Sign in to see all industry competitors for Biodexa Pharmaceuticals Plc.

Sign In Create Free Account



BDRX's Market share relative to its competitors, as of Q4 2025 within the Healthcare Sector
As of Q4 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2025		 MARKET SHARE
12 Months Ending
Q3 2025		 MARKET SHARE
MRQ
Q4 2025		 MARKET SHARE

Q3 2025
Biodexa Pharmaceuticals Plc 0.00% 0.00% 0.00 % 0.00 %
Amgen Inc 56.44% 49.17% 53.40% 51.09%
Teva Pharmaceutical Industries Limited 21.58% 25.39% 22.00% 23.61%
Viatris Inc 18.11% 21.04% 19.95% 20.85%
Acadia Pharmaceuticals Inc 1.36% 1.58% 1.64% 1.59%
Intra cellular Therapies Inc 0.85% 0.90% 1.06% 1.04%
14 more companies available

Sign in to see all sector competitors for Biodexa Pharmaceuticals Plc.

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Biodexa Pharmaceuticals Plc's market divisions, geographic dispersion, segments, products, and services, visit Biodexa Pharmaceuticals Plc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.